Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
ESP Logistics Technology Has 1st Closing on $5.0m Series A Round with Japan Post Group As Lead Investor
January 16, 2023 08:00 ET
|
ESP Logistics Technology
LOS ANGELES, Jan. 16, 2023 (GLOBE NEWSWIRE) -- ESP Logistics Technology (ESP), a company dedicated to solving global supply chain problems through our cloud-based geospatial platform, announced that...
RadioMedix announces a $40 million Series A financing for the advancement of novel Targeted Alpha Therapy platform and diagnostic companion radiopharmaceuticals to address unmet needs in oncology; Michael Lee-Chin appointed to the board of the company
October 07, 2022 18:11 ET
|
RadioMedix Inc.
HOUSTON and BURLINGTON, Ontario, Oct. 07, 2022 (GLOBE NEWSWIRE) -- RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced an agreement with an entity related...
4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing
June 07, 2022 08:30 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing 7 June 2022 London & Greater Philadelphia – 4BIO Capital...
AviadoBioTM Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform
December 02, 2021 02:00 ET
|
Aviadobio Ltd
AviadoBioTM Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform Series A led by New Enterprise Associates (NEA) and co-led by Monograph Capital follows...
ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset
June 30, 2021 07:00 ET
|
ArriVent Biopharma
Funds will be used to build ArriVent’s portfolio of innovative in-licensed assets for global development Company enters first licensing agreement with Allist Pharma, granting ArriVent ex-China...
Zylö Therapeutics Closes $4 Million Series A Financing
September 26, 2019 08:00 ET
|
Zylö Therapeutics
GREENVILLE, SC, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational topical delivery platform, announced that on September 21, 2019, it effected a...
Sermonix Pharmaceuticals Closes US$26 Million Series A Financing Round Led by WILD Family Office
July 31, 2019 10:00 ET
|
Sermonix Pharmaceuticals LLC
COLUMBUS, Ohio, July 31, 2019 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female-specific oncology products, today...
Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases
November 26, 2018 09:00 ET
|
Rheostat Therapeutics
CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Rheostat Therapeutics, a biotech company focused on the discovery of novel treatments for neurodegeneration, cognition and rare diseases, today...
Eta Compute Secures $8 Million Series A Financing to Accelerate Development of the 3rd Generation of Neural Networks
January 23, 2018 06:00 ET
|
Eta Compute
WESTLAKE VILLAGE, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Eta Compute Inc., a company focused on delivering 3rd generation machine intelligence to mobile and edge devices, today announced it has...
Unreel.me Raises $1.5 Million in Pre-Series A Financing To Scale Platform for OTT Video Networks
January 10, 2018 09:30 ET
|
IoT Broadband
SANTA MONICA, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Unreel.me, a leading platform for networks and publishers launching OTT streaming services, today announced it has raised $1.5 million in...